ZVRA

8.7603.42%
BB

Barney Bishop

Chairman of Scientific and Medical Advisory Board

Dr. Barney Bishop, Ph.D., is a Professor of General Biology and Protein Biochemistry at George Mason University. Dr. Bishop joined the laboratory of Dr. Lynne Regan at Yale University as a postdoctoral associate in order to continue his education and gain experience in the areas of molecular biology, protein engineering and protein biophysical characterization. His research focused on reengineering helical bundle proteins in order to enhance their stability. In 2001, Dr. Bishop joined New River Pharmaceuticals as a Senior Research Scientist. During his time at New River Pharmaceuticals, Dr. Bishop played a major role in the design and assembly of product lead candidates. He joined the Department of Chemistry and Biochemistry at George Mason University in the fall of 2003. His research interests include molecular engineering, antimicrobial peptides and the design of novel therapeutic agents for combating infection. Dr. Bishop has been the Chairman of scientific and Medical Advisory Board at Zevra Therapeutics, Inc. (formerly known as KemPharm, Inc.), since 2007. Dr. Bishop has been a member of the scientific and medical advisory board of Zevra Therapeutics, Inc. (formerly known as KemPharm, Inc.) since 2007. He serves as Member of Scientific Advisory Board of Ceres Nanosciences Inc since May 2018. Dr. Bishop received a Ph.D. in chemistry from the University of North Carolina at Chapel Hill in 1997, where his graduate research focused on peptide synthesis and engineering.

Positions